9月10日，丹麦制药巨头诺和诺德宣布，将在全球新一轮重组中裁员9000人，约占公司员工总数的11.5%，如此大规模的裁员在这家胰岛素及减重药巨头的百年历史上极为罕见，这也是诺和诺德更替CEO之后宣布的首项重大举措。诺和诺德公司在一份声明中表示：“诺和诺德今天宣布了一项全公司范围的重组计划，旨在精简组织架构、提高决策速度，并将资源重新分配，以抓住公司在糖尿病和肥胖症领域的增长机遇。”诺和诺德目前在...
Source Link9月10日，丹麦制药巨头诺和诺德宣布，将在全球新一轮重组中裁员9000人，约占公司员工总数的11.5%，如此大规模的裁员在这家胰岛素及减重药巨头的百年历史上极为罕见，这也是诺和诺德更替CEO之后宣布的首项重大举措。诺和诺德公司在一份声明中表示：“诺和诺德今天宣布了一项全公司范围的重组计划，旨在精简组织架构、提高决策速度，并将资源重新分配，以抓住公司在糖尿病和肥胖症领域的增长机遇。”诺和诺德目前在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.